Avidity Biosciences Inc (NASDAQ:RNA) has a beta value of 0.81 and has seen 6.01 million shares traded in the recent trading session. The company, currently valued at $3.64B, closed the recent trade at $38.10 per share which meant it gained $9.18 on the day or 31.74% during that session. The RNA stock price is 19.06% off its 52-week high price of $30.84 and 87.35% above the 52-week low of $4.82. The 3-month trading volume is 1.08 million shares.
Avidity Biosciences Inc (NASDAQ:RNA) trade information
Sporting 31.74% in the green today, the stock has traded in the green over the last five days, when the RNA stock price touched $38.10 or saw a rise of 2.93%. Year-to-date, Avidity Biosciences Inc shares have moved 321.00%, while the 5-day performance has seen it change 36.36%. Over the past 30 days, the shares of Avidity Biosciences Inc (NASDAQ:RNA) have changed 46.43%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Avidity Biosciences Inc (RNA) estimates and forecasts
Figures show that Avidity Biosciences Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 434.36% over the past 6 months, with this year growth rate of -6.53%, compared to 15.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -57.60% over the past 5 years.
RNA Dividends
Avidity Biosciences Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
